Hennion & Walsh Asset Management, Inc. Ptc Therapeutics, Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $880,746 - $1.04 Million	-24,908 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$37.01 - $44.74 $39,785 - $48,095	-1,075 Reduced 4.14%	24,908 $927,000
Q2 2021 Aug 13, 2021	BUY	$37.95 - $49.37 $2,239 - $2,912	59 Added 0.23%	25,983 $1.1 Million
Q1 2021 May 17, 2021	BUY	$46.8 - $68.92 $1.21 Million - $1.79 Million	25,924 New	25,924 $1.23 Million

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.